Download citation file:
From McMaster University, Hamilton, Ontario; University of Manitoba and the Public Health Agency of Canada, Winnipeg, Manitoba; and Ontario Provincial Laboratory, Toronto, Ontario, Canada.
Grant Support: Funded by the Canadian Institutes of Health Research (grant no. 69010).
Potential Financial Conflicts of Interest: None disclosed.
Reproducible Research Statement:Study protocol and data set: Not available. Statistical code: The code for the nonlinear mixed-effects modeling is available from Dr. Hanna (e-mail, firstname.lastname@example.org).
Requests for Single Reprints: Mark Loeb, MD, MSc, McMaster University, MDCL 3200, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada; e-mail, email@example.com.
Current Author Addresses: Dr. Loeb and Mr. Neupane: McMaster University, MDCL 3200, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.
Dr. Hanna: McMaster University, 1400 Main Street West, CE&B, IAHS Building, Room 408, Hamilton, Ontario L8S 1C7, Canada.
Dr. Nicolle: University of Manitoba, GG443-820 Sherbrook Street, Winnipeg, Manitoba R3N 0A3, Canada.
Dr. Eyles: McMaster University, 1280 Main Street West, General Sciences Building, Room 217, Hamilton, Ontario L8S 4K1, Canada.
Dr. Elliott: McMaster University, 1280 Main Street West, General Science Building, Room 229, Hamilton, Ontario L8S 4M4, Canada.
Dr. Rathbone: McMaster University/Henderson Hospital, 711 Concession Street, 70 Wing, Ground Floor, Room 23, Hamilton, Ontario L8V 1C3, Canada.
Dr. Drebot: National Microbiology Laboratory, 1015 Arlington Street, Winnipeg, Manitoba R3E 3R2, Canada.
Dr. Fearon: Canadian Blood Services, 87 College Street, Toronto, Ontario M5G 2M1, Canada.
Dr. Mahony: St. Joseph's Healthcare, 50 Charlton Avenue East, Luke Wing, Room 424, Hamilton, Ontario L8N 4A6, Canada.
Author Contributions: Conception and design: M. Loeb, S. Hanna, S. Elliott, J. Mahony, M. Rathbone.
Analysis and interpretation of the data: M. Loeb, S. Hanna, B. Neupane, M. Rathbone, M. Drebot.
Drafting of the article: M. Loeb, S. Hanna, M. Drebot.
Critical revision of the article for important intellectual content: M. Loeb, S. Hanna, J. Eyles, S. Elliott, J. Mahony, M. Rathbone, M. Drebot.
Final approval of the article: M. Loeb, S. Hanna, L. Nicolle, J. Eyles, J. Mahony, M. Rathbone, M. Drebot.
Provision of study materials or patients: M. Loeb, L. Nicolle, M. Drebot.
Statistical expertise: M. Loeb, S. Hanna, B. Neupane.
Obtaining of funding: M. Loeb, S. Hanna, J. Mahony.
Administrative, technical, or logistic support: M. Loeb, M. Fearon, J. Mahony.
Collection and assembly of data: M. Loeb, L. Nicolle.
Figure 1 illustrates the flow of study participants at different measurement dates. Of 367 participants, 156 (42.5%) were enrolled in the study (mean age, 52.0 years [SD, 13.5]; age range, 19 to 85 years; 76 [48.7%] women) (Table 1). Reasons for nonenrollment varied (patients did not call the study office back after receiving information [n = 71]; physicians could not be contacted or declined to contact the patient [n = 63]; patients declined participation [n = 38], did not meet eligibility criteria [n = 25], or died before enrollment [n = 7]; or the local hospital institutional review board approval could not be obtained in time [n = 7]). Age (52.0 years vs. 51.4 years; P = 0.73) or sex (49% men vs. 56% women; P = 0.22) did not significantly differ between enrolled and nonenrolled participants on the basis of the 45% of nonenrolled participants for whom demographic information was available.
ICU = intensive care unit.
Please read the other comments before posting. Contributors must reveal any conflict
Comments are moderated and will appear on the site at the discretion of The American
College of Physicians editorial staff. Please be sure your email address is
updated in your account, otherwise the American College of Physicians will not be
able to contact you about your comment.
Anyone can submit a comment any time after publication, but only those submitted within 4 weeks of an article’s publication will be considered for print publication. One month after publication, editors review all posted comments and select some for publication in the Letters section of the print version of Annals. (Not peer reviewed)
Authors: No more than 5
Text: Word Limit 400 (excludes references), 5 references, no figures or tables
* = Required Field
Disclosure of Any Conflicts of Interest*
(applies to the past 5 years and foreseeable future) Indicate any potential conflicts
of interest of each author below, including specific financial interests and relationships
and affiliations relevant to the subject matter or materials discussed in the manuscript
(eg, employment/affiliation, grants or funding, consultancies, honoraria, speakers
bureau, stock ownership or options, expert testimony, royalties, donation of medical
equipment, or patents filed, received, or pending). If all authors have none, check
"No potential conflicts or relevant financial interests" in the box below. Please
also indicate any funding received in support of this work. The information will
be posted with your response.
In the August issue of Annals of Internal Medicine, Dr, Mark Loeb, et al. produced an elegant study, "Prognosis after West Nile Virus Infection". The conclusion suggests that everyone with West Nile Virus, even the neuroinvasive type, will completely recover within one year. The results of this study have received widespread media attention. Unfortunately, the conclusion is not supported by the data and is misleading. This misleading conclusion is detrimental to our public health efforts to educate the public about the dangers of West Nile Virus and about why they should try to prevent getting mosquito bites.
As a survivor of West Nile Virus neuroinvasive disease, I run a support group for West Nile Virus victims in Dallas, Texas. Obviously, a support group represents a self-selected group of patients who have not had a good outcome. Nevertheless, we have many members who have lingering problems of extreme fatigue, cognitive delay, persistent muscle weakness from polio-like paralysis, balance problems, and/or muscle pain, even after two to four years. In this self-selected cohort of patients, it is certainly not true that everyone returned to normal within 12 months.
In Dr. Loeb's cohort of patients it is also not true that everyone returned to normal in 12 months. He specifically excluded the seven patients who died before enrollment (a 1.9% mortality rate), the three patients who died between 30 days and 24 months, and the seven patients with acute flaccid paralysis (4% of the cohort). One patient was excluded at day 30 because the patient was on a ventilator, which is the hallmark of the severest form of West Nile Virus.
A better conclusion from the data would be that most people recover from West Nile Virus and that those who are going to recover completely do so within one year.
Dr. Loeb's research into West Nile Virus is a critical step forward in our understanding of the short term outcome from the disease. More work is needed in looking at the long term outcomes.
Do People With West Nile Virus Infection Eventually Return to Normal Health?
The summary below is from the full report titled “Prognosis after West Nile Virus Infection.” It is in the 19 August 2008 issue of Annals of Internal Medicine (volume 149, pages 232-241). The authors are M. Loeb, S. Hanna, L. Nicolle, J. Eyles, S. Elliott, M. Rathbone, M. Drebot, B. Neupane, M. Fearon, and J. Mahony.
The In the Clinic® slide sets are owned and copyrighted by the American College
of Physicians (ACP). All text, graphics, trademarks, and other intellectual property
incorporated into the slide sets remain the sole and exclusive property of the ACP.
The slide sets may be used only by the person who downloads or purchases them and
only for the purpose of presenting them during not-for-profit educational activities.
Users may incorporate the entire slide set or selected individual slides into their
own teaching presentations but may not alter the content of the slides in any way
or remove the ACP copyright notice. Users may make print copies for use as hand-outs
for the audience the user is personally addressing but may not otherwise reproduce
or distribute the slides by any means or media, including but not limited to sending
them as e-mail attachments, posting them on Internet or Intranet sites, publishing
them in meeting proceedings, or making them available for sale or distribution in
any unauthorized form, without the express written permission of the ACP. Unauthorized
use of the In the Clinic slide sets will constitute copyright infringement.
to gain full access to the content and tools.
Learn more about subscription options